The synthesis and biological activities of 3-acyl- 2,3-dihydro-1,3,4-oxadiazole / 3-acyl-1,3,4-oxadiazoline derivatives obtained from hydrazide-hydrazones

Year 2012, Volume: 16 Issue: 2, 120 - 133, 07.03.2014

Sevim Rollas Sevgi Karakuş

Abstract

ABSTRACT: In this review, the synthesis and biological activities of 3-acyl-2,3-dihydro-1,3,4-
oxadiazole derivatives are reported. Synthesis of 1,3,4-oxadiazolines via carboxylic acid
hydrazide-hydrazones by using acetic anhydride or other cyclization agents establishes the
peculiar basis of our work.
KEYWORDS: 2,3-dihydro-1,3,4-oxadiazole, 3-acyl-1,3,4-oxadiazoline, hydrazide hydrazones,
biological activities.

Keywords

2, 3-dihydro-1, 3, 4-oxadiazole, 3-acyl-1, 3, 4-oxadiazoline, hydrazide hydrazones, biological activities

References

• Kitaev YP, Buzykin BI. The Reactions of Hydrazones. Russian Chem Rev 1972;41: 495-515.
• Rollas S. Synthesis and Spectrometric Analysis of Some Hydrazide Hydrazones I. J Fac Pharm Ist l98l; l7: 4l-50.
• Rollas S, Büyüktimkin S, Büyüktimkin N, Ülgen M. Yem- eni E. Evaluation of some arylhydrazones of N 2-aryli- denebenzylic acid hydrazide as antimicroial agents. Pharmazie 1988; 43: 511.
• Koçyiğit-Kaymakçıoğlu B, Oruç E, Unsalan S, Kan- demirli F, Shvets N, Rollas S, Anatholy D. Synthesis and characterization of novel hydrazide-hydrazones and the study their structure-antituberculosis activity. Eur J Med Chem 2006; 41: 1253-61.
• Rollas S, Küçükgüzel ŞG. Biological activities of hydra- zone derivatives. Molecules 2007; 12: 1910-39.
• Ergenç N, Günay NS. Synthesis and antidepressant eval- uation of new 3-phenyl-5-sulfonamidoindole deriva- tives. Eur J Med Chem 1993; 33: 143-8.
• Ling A, Plewe M, Gonzalez J, Madsen P, Sams CK, Lau J, Gregor V, Murphy D, Teston K, Kuki A, Shi S, Trues- dale L, Kiel D, May J, Lakis J, Anderes K, Iatsimirskaia E, Sidelmann UG, LB Knudsen, Brand CL, Polinsky A. Hu- man glucagon receptor antagonists based on alkylidene hydrazides. Bioorg Med Chem Lett 2002; 12: 663–6.
• Perdicchia D, Licandro E, Maiorana S, Baldoli C, Gian- nini C. A new ‘one-pot’ synthesis of hydrazides by re- duction of hydrazones. Tetrahedron 2003; 59: 7733–42.
• Elassar A-ZH, Dib HH, Al-Awadi NA, Elnagdi MH. Chemistry of carbofunctionally substituted hydrazones. Arkivoc 2007; (ii): 272-315.
• Belskaya NP, Dehaen W, Bakulev VA. Synthesis and properties of hydrazones bearing amide, thioamide and amidine functions. Arkivoc 2010; (i): 275-332.
• Richardson DR, Milnes K. The potential of iron chela- tors of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents II: The mechanism of action of ligands derived from salicylaldehyde benzoyl hydrazone and 2-hydroxy-1-naphthylaldehyde benzoyl hydrazone. Blood 1997; 89: 3025-38.
• Khattab SN. Synthesis and biological activity of novel amino acid-(N’-benzoyl)hydrazide and amino acid-(N’- nicotinoyl)hydrazide derivatives. Molecules 2005; 10: 1218-28.
• Johnson DK, Murphy TB, Rose NJ. Cytotoxic chelators and chelates 1. Inhibition of DNA synthesis in cultured rodent and human cells by aroylhydrazones and by a copper (II) complex of salicylaldehyde benzoyl hydra- zone. Inorg Chim Acta 1982; 67: 159-165.
• Richardson DR, Ponka P. Pyridoxal isonicotinoyl hy- drazone and its analogs: Potential orally effective iron- chelating agents fort the treatment of iron overload dis- ease. J Lab Clin Med 1998; 131: 307-15.
• Mohareb RM, Fleita DH, Sakka OK. Novel synthesis of hydrazide-hydrazones derivatives and their utilization in the synthesis of coumarin, pyridine, thiazole and thi- ophene derivatives with antitumor activity. Molecules 2011; 16: 16-27.
• Cui Z, Li Y, Ling Y, Huang J, Cui J, Wang R, Yang X. New class of potent antitumor acylhydrazone derivatives con- taining furan. Eur J Med Chem 2010; 45: 5576-84.
• Ajani OO, Obafemi CA, Nwinyi OC, Akinpelu DA. Mi- crowave assisted synthesis and antimicrobial activity of 2-quinoxalinone-3-hydrazone derivatives. Bioorg Med Chem 2010; 18: 214-21.
• Narasimhan B, Kumar P, Sharma D. Biological activities of hydrazide derivatives in the new millennium. Acta Pharma Sci 2010; 52: 169-180.
• Uppal G, Bala S, Kamboj S, Saini M. Therapeutic Review Exploring Antimicrobial potential of hydrazones as promising lead. der pharma chem 2011; 3: 250-68.
• Küçükgüzel ŞG, Mazi A, Şahin F, Öztürk S, Stables JP. Synthesis and biological activities of diflunisal hy- drazide-hydrazones. Eur J Med Chem 2003; 38: 1005-13.
• Özdemir A, Kaplancıklı ZA, Turan-Zitouni G, Revial G. Synthesis of some novel hydrazone derivatives and eval- uation of their antituberculosis activity. Marmara Pharm J 2010; 14:79-83.
• Gülerman NN, Oruç EE, Kartal F, Rollas S. In vivo me- tabolism of 4-fluorobenzoic acid [(5-nitro-2-furanyl) methylene] hydrazide in rats. Eur J Drug Metab Pharma- cokinet 2000; 25: 103-8.
• Kömürcü ŞG, Rollas S, Ülgen M, Gorrod JW, Çevikbaş A. Evaluation of some arylhydrazones of p-aminobenzoic acid hydrazide as antimicrobial agents and their in vitro hepatic microsomal metabolism. Boll Chim Farmaceuti- co-Anno 1995; 134: 281-5.
• Imramovsky´ A, Polanc S, Vinšová J, Kočevar M, Jam- pílek J, Zuzana Rečková, Kaustová J. A new modification of anti-tubercular active molecules. Bioorg Med Chem 2007; 15: 2551–59.
• Rollas S. Preclinical Development Handbook: ADME and Biopharmaceutical Properties Editors: Shayne Cox Gad, John Wiley & Sons, Inc. New Jersey 2008, pp. 829-851.
• Rollas S, Kucukguzel ŞG. Hydrazone, amide, carbamate, macromolecular and other prodrugs of Doxorubicin. Open Drug Deliv J 2008; 2: 77-85.
• Bildstein l, Dubernet C, Couvreur P. Prodrug-based in- tracellular delivery of anticancer agents. Adv Drug Deliv Rev 2011; 63: 2-23.
• Rawat J, Jain PK, Ravichandran V, Agrawal RK. Synthe- sis and evaluation of mutual prodrugs of isoniazid, p- amino salicylic acid and ethambutol. Arkivoc 2007; (i): 105-118.
• Kratz F. DOXO-EMCH (INNO-206): the first albumin- binding prodrug of doxorubicin to enter clinical trials. Expert Opin Investig Drugs 2007; 16: 855-66.
• Ducry L, Stump B. Antibody-Drug Conjugates: Linking Cytotoxic Payloads to Monoclonal Antibodies. Bioconju- gate Chem 2010; 21: 5–13.
• Küçükgüzel ŞG, Oruç EE, Rollas S, Şahin F, Özbek A. Synthesis, characterization and biological activity of novel 4-thiazolidino 1,3,4-oxadiazoles and some related compounds. Eur J Med Chem 2002; 37: 197-206.
• Cesur N, Cesur Z, Ergenç N, Uzun M, Kiraz M, Kasimo- glu Ö, Kaya D. Synthesis and antifungal activity of some 2-aryl-3-substituted 4-thiazolidinones. Arch Pharm (Weinheim) 1994; 327: 271-72.
• Kalsi R, Shrimali M, Bhalla TN, Barthwal JP. Synthesis and anti-inflammatory activity of indolyl azetidinones. Indian J Pharm Sci 2006; 41: 353-59.
• Kumar D, Bux FB, Singh Arun. Synthesis and biological activity of azetidinone. Rasāyan J Chem 2010; 3: 497-502.
• Mansour AK, Eid MM, Khalil NSAM. Synthesis and re- actions of some new heterocyclic carbohydrazides and related compounds as potantial anticancer agents. Mol- ecules 2003; 8: 744-55.
• Dobrotă C, Paraschivescu CC, Dumitru I, Matache M, Baciu I, Rută LL. Convenient preparation of unsymmet- rical 2,5-disubstituted 1,3,4-oxadiazoles promoted by Dess-Martin reagent. Tetrahedron Lett 2009; 50: 1886-88.
• Safieh KAA, Al-Titi AMS, Zahra JA, Ayoub MT. Oxida- tive cyclization of arylidene carboxyhydrazides: Synthe- sis of substituted hydroxydiphenylmethyl-1,3,4-oxadia- zoles. JJC 2007; 2: 211-8.
• Kovařiková P, Mokry M, Klimeš J, Vávrová K. HPLC study on stability of pyridoxal isonicotinoyl hydrazone. J Pharmaceut Biomed Anal 2006; 40: 105-112.
• Ülgen M, Barlas-Durgun B, Rollas S, Gorrod JW. The in-vitro hepatic microsomal metabolism of benzoic acid benzylidene hydrazide. Drug Metabol Drug Interact 1997; 13: 285-94.
• Hearn MJ, Chanyaputhipong PY. Preparation and spec- troscopic properties of 3-acyl-1,3,4-oxadiazolines. J Het- erocyclic Chem 1995; 32: 1647-49.
• Yale HL, Losee K, Martins J, Holsing M, Perry FM, Bern- stein J. Chemotherapy of experimental tuberculosis. VIII. The synthesis of acid hydrazides, their derivatives and related compounds. J Am Chem Soc 1953; 75: 1933-42.
• Somogyi Lászlό. Structure and reactions of aldose semi- carbazone and thiosemicarbazone derivatives under acetylating conditions. Carbohydr Res 1979; 75: 325-30.
• Hassan E, Al-Ashmawi MI, Abdel-Fattah B. Synthesis and antimicrobial testing of certain oxadiazoline and triazole derivatives. Pharmazie 1983; 38: 833-5.
• Ergenç N, Rollas S, Topaloğlu Y, Ötük G. Synthesis and characterization of new 1,3,4-oxadiazolines. Arch Pharm 1989; 322: 837-8.
• Rollas S, Gülerman NN, Erdeniz H. Synthesis and an- timicrobial activity of some new hydrazones of 4-fluor- obenzoic acid hydrazide and 3-acetyl-2,5-disubstituted- 1,3,4-oxadiazolines. Farmaco 2002; 57: 171-4.
• Rahman MMA, EL Ashry ESH, Abdallah AA, Rashed N.C-(Polyacetoxy)alkyloxadiazolines and related com- pounds. Carbohydr Res 1979; 73: 103-11.
• Maccioni E, Alcaro S, Cirilli R, Vigo S, Cardia MC, Sanna ML, Meleddu R, Yanez M, Costa G, Casu L, Matyus P, Distinto S. 3-Acetyl-2,5-diaryl-2,3-dihydro-1,3,4-oxadia- zoles: A new scaffold for the selective inhibition of Mon- aamine Oxidase B. J Med Chem 2011; 54: 6394-98.
• Somogyi L. Notes on the reactions of ketone acylhydra- zones under acylation conditions. Tetrahedron 1985; 41: 5187-90.
• Somogyi L. Stereochemical aspects of the formation of diastereo isomeric 3-acetyl-2-(polyacetoxyalkyl)-5-phe- nyl-2,3-dihydro-1,3,4-oxadiazoles. Carbohydr Res 1988; 182: 19-29.
• Somogyi L, Czugler M, Sohár P. Synthesis and stere- ostructure of some 5,5’-disübstituted-3-acetyl-2,2’-bi-2H- 1,3,4-oxa(thia)diazolines. Tetrahedron 1992; 48: 9355-62.
• Somogyi L. Synthesis, oxidation and dehydrogenation of cyclic N,O- and N,S- acetals. Part III. [1,2] Transforma- tion of N, O-acetals: 3-Acyl-1,3,4-oxadiazolines. J Hetero- cyclic Chem 2007; 44: 1235-46.
• Durgun B, Çapan G, Ergen N, Rollas S. Synthesis char- acterization and biological evaluation of new benzyli- denebenzohydrazides and 2, 5-disubstituted-2,3-dihy- dro-1,3,4-oxadiazolines. Pharmazie 1993; 48: 942-3.
• Büyüktimkin S, Rollas S, Ülgen M, Ötük G. Some 1,3,4-oxadiazoline derivatives prepared by starting form benzylic acid hydrazide arylhdrazones and their antimi- crobial evaluation. Pharmazie 1990; 45: 865.
• Fathy NM, Abdel-Motti F, Abdel-Megeid FME. Synthe- sis of some thienoquinoline derivatives with expected pharmacological activity. Com Fac Sci Univ Ank 1991; 37: 1-8.
• Khalil MA, El-Sayed OA, El-Shamy HA. Synthesis and antimicrobial evaluation of novel oxa(thia)diazolylqui- nolines and oxa(thia)diazepino[7,6-b]quinolines. Arch Pharm (Weinheim), 1993; 326: 489-92.
• Farghaly AAH. Synthesis, reactions and antimicrobial activity of some new indolyl-1,3,4-oxadiazole, triazole and pyrazole derivatives. J Chin Chem Soc 2004; 51: 147- 56.
• Mogilaiah K, Kumara Swamy T, Vinay Chandra A, Srivani N. Microwave assisted synthesis of 1,3,4-oxadia- zolyl 1,8-naphthyridines under solvent-free conditions using solid support. Indian J Chem 2009; 48(B): 1462-65.
• Dewangan D, Pandey A, Sivakumar T, Rajavel R, Dubey RD. Synthesis of some novel 2,5-disubstituted 1,3,4-oxa- diazole and its analgesic, anti-inflammatory, anti-bac- terial and anti-tubercular activity. Int J Chem Tech Res 2010; 2: 1397-412.
• Burch HA. Nitrofuryl Heterocycles. V. 4-Acyl-5,5-di- alkyl-2-(5-nitro-2-furyl)-D2-1,3,4-oxadiazolines. J Med Chem1967; 10: 91-3.
• Cerioni G, Maccioni E, Cardia MC, Vigo S, Mocci F. Characterization of 2,5-diaryl-1,3,4-oxadiazolines by multinuclear magnetic resonance and density functional theory calculations. Investigation on a case of very re- mote Hammett correlation. Magn Reson Chem 2009; 47: 727-33.
• Osório TM, Monache FD, Chiaradia LD, Mascarello A, Stumpf TR, Zanetti CR, Silveira DB, Barardi CRM, Smâ- nia EFA, Viancelli A, Garcia LAT, Yunes RA, Nunes RJ, Smânia A. Antibacterial activity of chalcones, hydrazones and oxadiazoles against methicillin-resistant Staphylococ- cus aureus. Bioorg Med Chem Lett 2012, 22: 225–30.
• Eid AI, Ragab FA, El-Ansary SL, El-Gazayerly SM, Mourad FE. Synthesis of new 7-substituted 4-methylcou- marin derivatives of antimicrobial activity. Arch Pharm (Weinheim)1994; 327: 211-3.
• Armesto D, Gallego MG, Horspool WM, Ramos A. Un- expected reactivity of the anion derived from benzophe- none benzoylhydrazone in the presence of electrophiles. Tetrahedron Lett 1988; 29: 3581-4.
• Bacu E, Couture A, Grandclaudon P. Synthesis and char- acterization of 2,2-disubstituted-5-(2-phenothiazin-10- ylethyl)-2,3-dihydro-1,3,4-oxadiazoles. Synth Commun 2003; 33: 143-151.
• Islam R, Mohsin M. Synthesis of isatin, 5-chloroisatin and their D2-1,3,4-oxadiazoline derivatives for com- parative study on brine shrimp. Bangladesh J Pharmacol 2007; 2: 7-12.
• Han D, Meng XB, Wang LN, Liu H, Yao Y, Wang Z, Yang ZJ, Liu ZM, Li ZJ. Efficient synthesis of a series of novel fructose-based 3-acetyl-5-alkyl-2,3-dihydro-1,3,4-oxadi- azole derivatives and studies of the reaction mechanism. Tetrahedron: Asymmetry 2009; 20: 399-410.
• Wang LN, Han D, Xu FF, Meng XB, Li ZJ. Microwave- assisted efficient synthesis of glucose-based 3-acetyl-5- alkyl-2,3-dihydro-1,3,4-oxadiazole derivatives catalyzed by sodium acetate. Carbohydr Res 2009; 344: 2113-9.
• Allam YA, Nawwar GAM . Facile synthesis of 3-spiroin- dolines. Heteroatom Chemistry 2002; 13: 207-10.
• Abadi AH, Eissa AAH, Hassan GS. Synthesis of novel 1,3,4-trisubstituted pyrazole derivatives and their evalu- ation as antitumor and antiangiogenic agents. Chem Pharm Bull 2003; 51: 838-44.
• Alho MMA, Moglioni AG, Brousse B, Moltrasio GY, D’Accorso NB. Synthesis and characterization of 2,2-dis- ubstituted thiadiazolines. Arkivoc 2000; (iv): 627-40.
• Ke S, Li Z, Qian X. 1,3,4-Oxadiazoline-3(2H)-carboxam- ide derivatives as potential novel class monoamine oxi- dase (MAO) inhibitors: Synthesis, evaluation, and role of urea moiety. Bioorg Med Chem 2008; 16: 7565-72.
• Ke S, Liu F, Wang N, Yang Q, Qian X. 1,3,4-Oxadiazoline derivatives as novel potential inhibitors targeting chitin biosynthesis: Design, synthesis and biological evalua- tion. Bioorg Med Chem Lett 2009; 19: 332-5.
• Tsoleridis CA, Stephanidou-Stephanadou J, Gounaridis P, Zika H, Pozarentzi M. Unusual reaction of N-aroyld- ihydrocyclopenta-pyrazolidinol with ketenes: formation of 1,3,4-oxadiazoles. Tetrahedron 2003; 59: 4591-601.
• Desai NC, Dodiya AM. Conventional and microwave techniques for synthesis and antimicrobial studies of novel 1-[2-(2-chloro(3-quinolyl))-5-(4-nitrophenyl)- (1,3,4-oxadiazolin-3-yl)]-3-(aryl)prop-2-en-1-ones. Med Chem Res 2011; DOI: 10.1007/s00044-011-9670-9.
• Gülerman N, Rollas S, Kiraz M, Ekinci AC, Vidin A. Evaluation of antimycobacterial and anticonvulsant activities of new 1-(4-fluorobenzoyl)-4- substituted-thi- osemicarbazide and 5-(4-fluorophenyl)-4-substituted- 2,4-dihydro-3H-1,2,4-triazole-3-thione derivatives. Far- maco 1997; 52: 691-5.
• Shaker RM. The chemistry of mercapto- and thione- sub- stituted 1,2,4-triazoles and their utility in heterocyclic synthesis. Arkivoc 2006; (ix): 59-112.
• Rollas S, Karakuş S, Barlas-Durgun B, Erdeniz H, Kiraz M. Synthesis and antimicrobial activity of some 1,4-dis- ubstituted thiosemicarbazide and 2,5- disubstituted 1,3,4-thiadiazole derivatives. Farmaco 1996; 51: 811-4.
• Oruç EE, Rollas S, Kandemirli F, Shvets N, Dimoglo A. 1,3,4-Thiadiazole derivatives. Synthesis, structure eluci- dation, and structure-antituberculosis activity relation investigation. J Med Chem 2004; 47: 6760-67.
• Feng D, Huang Y, Chen R, Yu Y, Song H. A novel of 2,5-disubstituted 1,3,4-oxadiazolines by the regioselec- tive cyclization of 1,4-disubstituted thiosemicarbazides. Synthesis 2007; 12: 1779-84. 80. sam K, Pole DL, Tadey T, Warkentin J. 2,2-Dialkoxy-D3- 1,3,4-oxadiazolines: Convenient Thermal Sources of Di- alkoxycarbenes. J Am Soc 1992; 114: 8751-2.
• El Kaim L, Le Menestrel I, Morgentin R. Trichloroacetic acid hydrazones I: New formation of 1,3,4-oxadiazoles from aldehydes. Tetrahedron Lett 1998; 39: 6885-8.
• Fuloria NK, Singh V, Shaharyar M, Ali M. Synthesis and antimicrobial evaluation of some new oxadiazoles de- rived from phenylpropionohydrazides. Molecules 2009; 14: 1898-903.
• Joshi SD, Vagdevi HM, Vaidya VP, Gadaginamath GS. Synthesis of new 4-pyrrol-1-yl benzoic acid hydrazide analogs and some derived oxadiazole, triazole and pyr- role ring systems: A novel class of potential antibacte- rial and antitubercular agents. Eur J Med Chem 2008; 43: 1989-996.
• Baquero E, Quinones W, Ribon W, Caldas ML, Sarmien- to L, Echeverri F. Effect of an oxadiazoline and a lignan on mycolic acid biosynthesis and ultrastructural changes of Mycobacterium tuberculosis. Hindawi Publishing Corporation Tuberculosis Research and Treatment 2011; 1-6.
• Chawla R, Arora A, Parameswaran MK, Sharma PC, Michael S, Ravi TK. Synthesis of novel 1,3,4-oxadiazole derivatives as potential antimicrobial agents. Acta Pol Pharm 2010; 67: 247-53.
• Yang JF, Cao H, Liu H, L, BQ, Ma YM. Synthesis and bioactivity of novel bis-heterocyclic compounds contain- ing pyrazole and oxadiazoline. J Chin Chem Soc 2011; 58: 369-75.
• Hamdi N, Passarelli V, Romerosa A. Synthesis, spectros- copy and electrochemistry of new 4-(4-acetyl-5-substi- tuted-4,5-1,3,4-oxodiazol-2-yl)methoxy)-2H-chromen-2- ones as a novel class of potential antibacterial and anti- oxidant derivatives. CR Chimie 2011; 14: 548-55.
• Ishii M, Jorge SD, de Oliveria AA, Palace-Berl F, Sonehara IY, Pasqualoto KFM, Tavares LC. Synthesis, molecular modeling and preliminary biological evaluation of a set of 3-acetyl-2,5-disubstituted-2,3-dihydro-1,3,4-oxadiazole as potential antibacterial, anti-Trypanosoma cruzi and anti- fungal agents. Bioorg Med Chem 2011; 19: 6292-301.
• Ali OM, , Amer HH, Abdel-Rahman AAH. Synthesis and antiviral valuation of sugar uracil-1-ylmethylhydra- zones and their oxadiazoline derivatives. Synthesis 2007; 18: 2823-8.
• El-Emam AA, Alrashood KA, Al-Omar MA, Al-Tamimi AMS. Synthesis and antimicrobial activity of N’-heteroaryli- dene-1-adamantylcarbohydrazides and (±)-2-(1-adamantyl)- 4-acetyl-5-[5-(4-substitutedphenyl-3-isoxazoly)]-1,3,4-oxadi- azolines. Molecules 2012; 17: 3475-83.
• Manojkumar P, Kochupappy R, Subbuchettiar G. Syn- thesis of coumarin heterocyclic derivatives with anti- oxidant activity anda in vitro cytotoxic activity against tumour cells. Acta Pharm 2009; 59: 159-70.
• Jin L, Chen J, Song B, Chen Z, Yang S, Li Q, Hu D, Xu R. Synthesis, structure, and bioactivity of N’- substituted benzylidene-3,4,5-trimethoxybenzohy- drazide and 3-acetyl-2-substituted phenyl-5-(3,4,5- trimethoxyphenyl)-2,3-dihydro-1,3,4-oxadiazole deriva- tives. Bioorg Med Chem Lett 2006; 16: 5036-40.
• Lee L, Robb LM, Lee M, Davis R, Mackay H, Chavda S, Babu B, O’Brien EL, Risinger AL, Mooberry SL, Lee M. Design, synthesis, and biological evaluations of 2,5-di- aryl-2,3-dihydro-1,3,4-oxadiazoline analogs of Combre- tastatin–A4. J Med Chem 2010; 53: 325-34.
• Chimenti F, Bolasco A, Manna F, Secci D, Chimenti P, Befani O, Turini P, Giovannini V, Mondovi B, Cirilli R, La Torre F. Synthesis and selective inhibitory activity of 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole deriva- tives against Monaamine oxidase. J Med Chem 2004; 47: 2071-4.
• Doğan HN, Rollas S, Erdeniz H. Synthesis, structure elu- cidation and antimicrobial activity of some 3-hydroxy-2- naphthoic acid hydrazide dervatives. Farmaco 1998; 53: 462-7.
• Şener G, Keyer-Uysal M, Doğan HN, Rollas S. 2-(3-Acety- loxy-2-naphthyl)-4-acetyl-5-phenyl-1,3,4-oxadiazoline suppresses pentylenetetrazol-induced convulsive and oxidative activity on mice. Acta Pharm Turcica 2003; 45: 61-7.
• Hu Y, Lu X, Chen K, Yan R, Li QS, Zhu-HL. Design, syn- thesis, biological evaluation and molecular modeling of 1,3,4-oxadiazoline analogs of combretastatin–A4 as nov- el antitubulin agents. Bioorg Med Chem 2012, 20: 903-9.
• Koçyiğit-Kaymakçıoğlu B, Oruç-Emre EE, Ünsalan S, Tabanca N, Khan SI, Wedge DE, İşcan G, Demirci F, Rollas S. Synthesis and biological activity of hydrazide- hydrazones and their corresponding 3-acetyl-2,5-disub- stituted-2,3-dihydro-1,3,4-oxadiazoles. Med Chem Res 2011; DOI 10.1007/s00044-011-9882-z.